Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
European Journal of Clinical Investigation|October 10, 2013
Proposed score for survival of patients with myelodysplastic syndromesWolfgang R Sperr, Michael Kundi, Friedrich Wimazal, et al.
Blood|January 13, 2005
A functional single-nucleotide polymorphism of the G-CSF receptor gene predisposes individuals to high-risk myelodysplastic syndromeAlbert Wölfler, Stefan J Erkeland, Claudia Bodner, et al.
International Journal of Molecular Sciences|February 15, 2019
Clonal Hematopoiesis with Oncogenic Potential (CHOP): Separation from CHIP and Roads to AMLPeter Valent, Wolfgang Kern, Gregor Hoermann, et al.
British Journal of Haematology|November 12, 2023
Survival outcomes in patients with acute myeloid leukaemia who received subsequent therapy for relapse in QUAZAR AML-001Farhad Ravandi, Hartmut Döhner, Andrew H Wei, et al.
Wiener Klinische Wochenschrift|July 21, 2010
[Tumor stem cell research - basis and challenge for diagnosis and therapy]Heidrun Karlic, Harald Herrmann, Axel Schulenburg, et al.
European Journal of Haematology|March 17, 2022
Multistep pathogenesis of chronic myelomonocytic leukemia in patientsKlaus Geissler, Eva Jäger, Agnes Barna, et al.
International Journal of Molecular Sciences|August 27, 2020
Molecular Basis and Clinical Application of Growth-Factor-Independent In Vitro Myeloid Colony Formation in Chronic Myelomonocytic LeukemiaKlaus Geissler, Eva Jäger, Agnes Barna, et al.
Cancers|July 18, 2020
Clinical, Hematologic, Biologic and Molecular Characteristics of Patients with Myeloproliferative Neoplasms and a Chronic Myelomonocytic Leukemia-Like PhenotypeSonja Heibl, Bettina Gisslinger, Eva Jäger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2011
Coalesced multicentric analysis of 2,351 patients with myelodysplastic syndromes indicates an underestimation of poor-risk cytogenetics of myelodysplastic syndromes in the international prognostic scoring systemJulie Schanz, Christian Steidl, Christa Fonatsch, et al.
Wiener Klinische Wochenschrift|February 1, 2018
Establishment and validation of a novel risk model for estimating time to first treatment in 120 patients with chronic myelomonocytic leukaemiaFlorian Huemer, Lukas Weiss, Viktoria Faber, et al.
Pageof 6